Key trial updates at SABCS 2020: monarchE, RxPONDER & ASCENT
The San Antonio Breast Cancer Symposium (SABCS) 2020 annual meeting took place virtually this year and showcased recent advances in the treatment and management of breast cancer.
In this podcast, Priya Rastogi, MD, of the University of Pittsburgh, Pittsburgh, PA, Sara M. Tolaney, MD, MPH, of the Dana-Farber Cancer Institute, Boston, MA, and Sara Hurvitz, MD, of Ronald Reagan UCLA Medical Center, Los Angeles, CA, outline key trial updates presented at SABCS 2020, including the primary outcome results of the monarchE study (NCT02107703), the practice-changing findings of RxPONDER (NCT01272037), and the updated biomarker analysis of the ASCENT study (NCT02574455). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
The post Key trial updates at SABCS 2020: monarchE, RxPONDER & ASCENT appeared first on VJOncology.
Create your
podcast in
minutes
It is Free